was gonna post this end of Q3 but honestly I've done so little that w/e, I'll just do it now as I don't really see myself doing much going into eoy barring serious material news
Sold out: NVO, AMLX
New: ODTX, CTNM
some of the cope on $SGMO is unreal.
They knew Sandy was a bad CEO and they knew the co was running out of cash and not only did they stay long, many of them averaged down.
With all this finger-pointing I doubt any of these idiots actually learned their lesson.
anyways $XBI at 160, so has already erased July losses, mb new 52 week high soon
Just buy quality, know your risk/exposure, and let time do its thing
nothing new here but it works
quite the fade on $DFTX.
if people want to nitpick vs phase 2b than fine but this is still an incredibly efficacious intervention that basically works immediately vs SSRI/SNRI and is dosed once in 12 weeks, with vast majority of AEs resolved on dosing day.
I think so. I am pretty skeptical on commercial potential, so this is good enough for me to get off this train at a $2.5B mkt cap when VOGX is likely to come in under $200M when it IPOs
Can't complain, wasn't in this name in size, but a win is a win.
